Markets:

Overview

News

Currencies

International

Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

8.740 -0.190 (-2.13%)

Official Closing Price Updated: 4:10 PM EDT, Mar 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biohaven Ltd. Common Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review ↗

September 29, 2023

But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus.

Via Investor's Business Daily

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet ↗

September 29, 2023

Investors are constantly on the hunt for undervalued, under-followed, and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 27, 2023

Via Benzinga

What's Going On Pfizer's Subsidiary Biohaven Stock? ↗

September 27, 2023

Pfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an

Via Benzinga

NYSE:BHVN Investor Alert: Investigation Concerning Possible Securities Laws Violations by Biohaven Ltd. ↗

August 23, 2023

San Diego, CA -- (SBWIRE) -- 08/23/2023 -- Biohaven Ltd. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Biohaven Stock Is Plunging Today - Here's Why ↗

July 27, 2023

Biohaven Ltd (NASDAQ: BHVN) shares are down after the company announced multiple

Via Benzinga

Why Biohaven Stock Is Crashing Today ↗

July 27, 2023

The clinical-stage biotech is going to remain in the clinical stage longer than it hoped.

Via The Motley Fool

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 27, 2023

Gainers

Via Benzinga

Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29% ↗

September 27, 2023

The companies hope by lowering immunoglobulin G, an antibody, that they can treat myriad autoimmune diseases.

Via Investor's Business Daily

Why Biohaven Stock Is Skyrocketing Today ↗

September 27, 2023

Promising clinical trial data led investors to bid the stock up, adding to its solid year-to-date gain.

Via The Motley Fool

Why Biohaven Stock Caught Fire This Week ↗

June 02, 2023

Investors are excited about the company's recent progress.

Via The Motley Fool

Recap: Biohaven Q1 Earnings ↗

May 12, 2023

Via Benzinga

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Leading the Way in Wednesday Trading Based on Percentage Gain

September 27, 2023

Via Investor Brand Network

MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday ↗

September 27, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

US Stocks Open Higher; Costco Posts Upbeat Earnings ↗

September 27, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.14% to 33,664.90 while the NASDAQ...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 27, 2023

Via Benzinga

Cramer Warns Investors About This AI Company Up 146% YTD: 'Too Much Hype, Too Much Fluff' ↗

September 20, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Micron Technology, Inc. (NASDAQ: MU) is "coming out of the trough, I agree with the hype.

Via Benzinga

Topics Artificial Intelligence

$2M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying ↗

August 08, 2023

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 27, 2023

Via Benzinga

Will The Dow Make History Today With A 14 Straight? ↗

July 27, 2023

The blue-chip index is slightly above breakeven at midday, while the S&P 500 Index and Nasdaq Composite are higher after another batch of earnings.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 27, 2023

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

2 Growth Stocks With Major Incoming Catalysts ↗

June 27, 2023

Binary events slated for July could quickly send these biotech stocks through the roof.

Via The Motley Fool

Top 5 Health Care Stocks That May Crash This Month ↗

June 22, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗

June 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run ↗

June 01, 2023

Shares surged into and out of the company's R&D Day, which included a surprise.

Via Investor's Business Daily

Tower Semiconductor, XP And 3 Stocks To Watch Heading Into Monday ↗

May 15, 2023

With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns ↗

March 31, 2023

The first quarter of 2023 was positive for the U.S. stock market as a whole, with the S&P 500 index faithfully tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), rising by 6%.

Via Benzinga

Week In Review: HighlightLL Pharma Out-Licenses Parkinson's Treatment To Biohaven For $970 Million ↗

March 25, 2023

HighlightLL Pharma out-licensed rights to its novel oral, brain-penetrating, dual inhibitor to New Haven’s Biohaven in a deal worth up to $970 million. Biohaven will have global rights to the product...

Via Talk Markets

Analysts Holding As Pfizer Waits On Two Phase 3 Studies

February 24, 2023

Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.

Via MarketBeat

Topics Bankruptcy

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.